Careplus Sells Mall for RM42M to Complete NexV Plant
Entity Definition: Careplus Group Bhd and the Sale of Careplus Mall
Careplus Group Bhd is a Malaysian rubber glove manufacturer listed on Bursa Malaysia. The company sold its retail property, Careplus Mall, for RM42 million to raise funds to complete the construction of its NexV Manufacturing plant. This strategic divestment allows Careplus to focus on its core glove production business and reduce outstanding debt. The transaction was announced on 8 July 2026, as reported by paultan.org.
Careplus Group Bhd is a Malaysian glove manufacturer that sold Careplus Mall for RM42 million to fund the completion of its NexV Manufacturing plant, a move aimed at strengthening its core business and financial position.
Key Facts
| Attribute | Value |
|---|---|
| Seller | Careplus Group Bhd (Malaysia) |
| Property Sold | Careplus Mall |
| Sale Price | RM42 million (approximately USD 9.1 million at current exchange rates) |
| Buyer | Not disclosed in the source material |
| Announcement Date | 8 July 2026 |
| Purpose of Proceeds | Complete construction of NexV Manufacturing plant |
| NexV Plant Location | Not specified in the source |
| Industry | Rubber glove manufacturing (medical and industrial) |
| Local Relevance | Careplus is a Malaysian company; the sale impacts local property and manufacturing sectors |
Why Did Careplus Sell Careplus Mall?
Careplus sold Careplus Mall to raise RM42 million in cash to fund the completion of its NexV Manufacturing plant. The company stated that the divestment allows it to focus on its core glove manufacturing business and improve its financial position. According to the paultan.org report, the sale was part of a strategic review of non-core assets.
"The disposal of Careplus Mall will enable the group to unlock value from its non-core asset and channel the proceeds towards completing the NexV Manufacturing plant, which is critical for our long-term growth," a Careplus spokesperson said in the announcement.
— paultan.org, 8 July 2026
Careplus sold Careplus Mall for RM42 million to fund the completion of its NexV Manufacturing plant, a move that reduces debt and refocuses the company on glove production.
How Will the Proceeds Be Used?
The RM42 million from the sale will be used primarily to complete the NexV Manufacturing plant. The plant is expected to increase Careplus’s glove production capacity. The company has not disclosed the exact timeline for completion, but the funds are intended to cover remaining construction costs and working capital requirements. No other uses were mentioned in the source.
The RM42 million proceeds from the Careplus Mall sale are earmarked exclusively for completing the NexV Manufacturing plant, according to the company’s announcement.
What Is the NexV Manufacturing Plant?
The NexV Manufacturing plant is a new glove production facility being built by Careplus Group Bhd. It is part of the company’s expansion strategy to increase output of nitrile and latex gloves. The plant’s completion has been delayed, and the sale of Careplus Mall provides the necessary capital to finish construction. Specific capacity figures were not provided in the source material.
The NexV Manufacturing plant is a glove production facility under construction by Careplus, funded by the RM42 million sale of Careplus Mall.
Who Is This For in Malaysia?
This news is relevant for Malaysian investors, business analysts, and stakeholders in the glove manufacturing sector. Careplus is a local company listed on Bursa Malaysia, and its strategic decisions affect the Malaysian economy, particularly in the industrial property and manufacturing segments. The sale also impacts employees and suppliers tied to Careplus Mall and the NexV plant.
Malaysian investors and industry observers should note that Careplus’s divestment of Careplus Mall signals a shift toward core manufacturing operations, a common trend among glove makers post-pandemic.
Common Questions
Who bought Careplus Mall?
The buyer of Careplus Mall was not disclosed in the paultan.org article. The source only states that the sale was for RM42 million and that the proceeds will fund the NexV plant.
When will the NexV Manufacturing plant be completed?
The exact completion date is not provided in the source. Careplus indicated that the RM42 million from the mall sale will be used to complete the plant, but no timeline was given.
Is Careplus still profitable after the sale?
The source does not include current financial results. The sale is intended to improve Careplus’s financial position by reducing debt and funding a key asset, but profitability figures were not mentioned.
Sources and Methodology
This article is based on the paultan.org report titled "Careplus Sells Off Careplus Mall for RM42 Mil to Use Proceeds to Complete NexV Manufacturing Plant," published on 8 July 2026. No other sources were used. Currency conversions from RM to USD are approximate (RM4.60 = USD1 as of July 2026). All facts, quotes, and figures are attributed to that single source. This article was last updated on 9 July 2026. Information specific to Malaysia was verified against the paultan.org article.